Skip to content
Search

Latest Stories

IT outage update: NPA urges patience as pharamcy services face delays

IT outage update: NPA urges patience as pharamcy services face delays

Services including accessing prescriptions from GPs and medicine deliveries were disrupted due to global IT outages last week 

The National Pharmacy Association (NPA) has provided an update on the ongoing recovery efforts following last week's IT outage, which affected community pharmacies across the UK.


Nick Kaye, Chair of the NPA, has urged patients to be patient with their local pharmacy teams as service in some community pharmacies may be slower than usual today.

"As pharmacists recover from last week's IT outage and catch up on the backlog of prescriptions, we expect service in some community pharmacies to be slower than usual today.

"Please be patient with your local pharmacy team if you are visiting them, as they may still be prioritising emergency prescriptions from their local GP surgeries as well as experiencing increased demand as services return to normal.”

Kaye commended the resilience and dedication of community pharmacists amid the challenges. "As ever, community pharmacies have worked hard to provide support for those who need them during this period," he noted.

Providing an update on the IT outage recovery, an NHS spokesperson also confirmed that systems are now back online and encouraged patients with scheduled NHS appointments to attend as planned unless they receive specific instructions not to.

The spokesperson acknowledged the efforts of NHS staff in managing the incident and minimising further disruptions. "Thanks to the hard work of NHS staff throughout this incident we are hoping to keep further disruption to a minimum, however there still may be some delays as services recover, particularly with GPs needing to rebook appointments, so please bear with us," they said.

A massive global technology outage on Friday disrupted essential services, including healthcare, airlines, banks, and broadcasters worldwide.

The outage, attributed to a flawed update from cybersecurity firm CrowdStrike, also affected the National Health Service (NHS) in the UK, with several hospitals and GP practices losing access to their computer systems.

Community pharmacies have been facing significant disruptions as services such as accessing prescriptions from GPs and medicine deliveries were affected, causing inconvenience to patients and healthcare providers.

An NHS spokesperson said: “The NHS is aware of a global IT outage and an issue with EMIS, an appointment and patient record system, which is causing disruption in the majority of GP practices.”

The spokesperson assured that the NHS has long-standing measures in place to manage such disruptions, including the use of paper patient records and handwritten prescriptions, and the usual phone systems to contact GPs.

“There is currently no known impact on 999 or emergency services,” said the spokesperson, urging people to continue using these services as they normally would.

Patients are advised to attend appointments unless told otherwise, and only contact GPs for urgent matters, recommending the use of 111 online or calling 111 for other concerns.

The National Pharmacy Association (NPA) acknowledged that global IT outages have disrupted services in some community pharmacies, including accessing prescriptions from GPs and medicine deliveries.

A spokesperson for the National Pharmacy Association (NPA) said that they are urgently raising this issue with NHS England and urged patients to be patient when visiting their pharmacies.

Cause of the global IT outage  

The global outage affecting Microsoft Windows computers has been attributed to CrowdStrike, a cybersecurity firm whose software is widely used across various industries worldwide to protect against hackers and external breaches.

Independent cybersecurity researcher and consultant Lukasz Olejnik told The New York Times that the problem may have been caused by a flawed security update of CrowdStrike software called Falcon Sensor.

According to Olejnik, an updated fix has been issued, but it remains unclear how long it will take to fully resolve the problem.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less